Your search for supplemental oxygen returned 7 results

Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.

Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.

Investigators evaluated the relationship between atopic dermatitis and frequency of severity markers in patients hospitalized with COVID-19.

Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.

Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air

Patients with chronic, noncancer-related pain who received fentanyl buccal tablet had consistent short-term efficacy across clinically meaningful analgesia measures, according to results of a study presented at the American Pain Society’s 31st Annual Scientific Meeting.

The MoxDuo combination of morphine and oxycodone may have a superior respiratory safety profile to that of equianalgesic morphine equivalent doses (MED) of either morphine or oxycodone alone, according to results presented at the American Pain Society’s 30th Annual Scientific Meeting.